Skip to content
OpenCapital
Get started

Corcept Therapeutics CORT Q3 2025 earnings

Reported November 4, 2025 · After market close

Revenue$207.6MMiss by $47.7M
EPS$0.16Miss by $0.02
Revenue estimate$255.3M
EPS estimate$0.18

Next report

Date not yet announced

Financials

Q3 2025

Income statement

See full
Revenue$207.6M+13.7%
Gross profit$203.0M+13.0%
Operating income$10.2M-78.1%
Net income$19.7M-58.3%
EPS (diluted)$0.16-61.0%

Balance sheet

See full
Cash & equivalents$125.1M-8.9%
Total debt$6.4M-6.4%
Total equity$631.9M-1.1%
Total assets$823.6M+5.0%

Cash flow

See full
Operating cash flow$54.5M-26.2%
CapEx--100%
Free cash flow$54.5M-24.5%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$8.76B+81.1%
Enterprise value$8.64B+83.6%
P/E82.5×+48.4×
P/S11.8×+4.1×

Profitability

See full
Gross margin98.2%-0.2pp
Operating margin8.8%-14.0pp
Net margin14.3%-8.2pp
FCF margin21.9%-0.8pp

Returns & leverage

See full
Return on equity16.7%-9.1pp
Debt / equity0×0.0×
Current ratio3.1×-0.6×

Versus estimates

Revenue

Q2 2026$256.1MBeat by $35.0MQ1 2026$164.9MMiss by $20.9MQ4 2025$202.1MMiss by $52.8M
Q3 2025$207.6MMiss by $47.7M
Q2 2025$194.4MMiss by $50.1MQ1 2025$157.2MMiss by $59.5M

Diluted EPS

Q2 2026$0.36Beat by $0.34Q1 2026-$0.30Miss by $0.16Q4 2025$0.20Miss by $0.13
Q3 2025$0.16Miss by $0.02
Q2 2025$0.29Beat by $0.06Q1 2025$0.17In line

Ask the moment Corcept Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Corcept Therapeutics report Q3 2025 earnings?
Corcept Therapeutics (CORT) reported Q3 2025 earnings on November 4, 2025 after market close.
What were Corcept Therapeutics's Q3 2025 revenue and EPS?
Corcept Therapeutics reported revenue of $207.6M and eps of $0.16 for Q3 2025.
Did Corcept Therapeutics beat estimates in Q3 2025?
Revenue missed the consensus estimate of $255.3M by $47.7M. EPS missed the consensus estimate of $0.18 by $0.02.
How did Corcept Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 13.7% from $182.5M a year earlier and eps declined 61.0% from $0.41.
Where can I find Corcept Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-048814) and the 10-Q periodic report (0001628280-25-048841) directly on SEC EDGAR. The filing index links above go to sec.gov.